Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar
PMC(0)


Article History
Submitted: 25 Jan 2014
Revised: 23 Aug 2014
First published online: 01 Jun 2015

Article Access Statistics
Abstract Page Views: 334
PDF Downloads: 138
Full Text Views: 0

Adv Pharm Bull. 2015;5(2):237-245 doi: 10.15171/apb.2015.033
PMID:26236663        PMCID:PMC4517079

Experimental Design to Predict Process Variables in the Microcrystals of Celecoxib for Dissolution Rate Enhancement Using Response Surface Methodology

Original Research

Mitra Jelvehgari, Hadi Valizadeh * , Seyed Hassan Montazam, Sanam Abbaszadeh


Abstract
Purpose: The purpose of the present investigation was to increase the solubility and dissolution rate of celecoxib (CLX) by preparing microcrystals of drug by solvent change precipitation. Methods: This procedure was optimized in order to obtain stable and homogeneous particles with a small particle size, high yield and fast dissolution rate. CLX agglomerates were prepared with brij35 (stabilizer agent) using acetone as solvent, water as non-solvent, respectively. The agglomerates were characterized by DSC, XRD, FTIR studies. A full-factorial design was employed to study the effect of independent variables, the amounts of stirring rate (X1), volume of organic solvent (X2), volume of aqueous solvent (X3), time of stirring (X4), concentration of Brij (X5), concentration of Tween 80 (X6), concentration of HPMC (X7) on dependent variables, particle size (PS), drug content (DC), drug released after 15 min (Q15), crystal yield (CY), Gibbs free energy change (ΔG°tr), antalpy change (ΔH) and saturated solubility (Ss). Results: The DSC and FTIR results indicated the absence of any interactions between drug and stabilizers. These studies showed a decrease in crystalinity in agglomerates. The crystals exhibited significantly improved micromeritic properties compared to pure drug. The drug content and crystal yield were in the range of 32.84-48.22% and 64.55-83.33% with all formulations, respectively. The solubility and drug release rates increased with an increase in concentration of stabilizer. Conclusion: The results show that microcrystals of the drug in stabilizer considerably enhanced the dissolution rate.





Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Jelvehgari M
Articles by Valizadeh H
Articles by Montazam SH
Articles by Abbaszadeh S

PubMed
Articles by Jelvehgari M
Articles by Valizadeh H
Articles by Montazam SH
Articles by Abbaszadeh S

Similar articles in PubMed

Share this article!

Press Manuscript Online. Powered by MAADRAYAN